The Medical University of South Carolina and UT Southwestern Medical Center join Spark Biomedical in Phase II clinical trial.
Spark Biomedical, Inc, the Hazelden Betty Ford Foundation, and Gaudenzia, Inc. Unite in Effort to Help Patients Reduce Relapse Risks and Sustain Recovery From Opioid Use Disorder
Spark Biomedical, Inc enlists the expertise of former Deputy Secretary of the U.S. Department of Health and Human Services (HHS), Eric D. Hargan, and his consulting firm, The Hargan Group, to help make novel withdrawal relief treatment more accessible and affordable for patients
